A carregar...
Introduction of biosimilar insulins in Europe
Regulatory approval of the first biosimilar insulin in Europe, LY2963016 insulin glargine (Abasaglar(®)), in 2014 expanded the treatment options available to people with diabetes. As biosimilar insulin products come to market, it is important to recognize that insulin products are biologicals manufa...
Na minha lista:
| Publicado no: | Diabet Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5637898/ https://ncbi.nlm.nih.gov/pubmed/28608570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dme.13400 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|